Metraipolis › archive › dc_1336dcd85807

Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment — Europe PMC PMID:41632514

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41632514
DOI
10.7554/elife.99225
License (as archived)
solo-consultazione
Archived
2026-11-06T04:02:06.484Z
SHA-256 of the archived text
6bbc9e0f375b3c8826daf21eeb609d746e8c99a7e435b23a4b86771c29eef6f9
Stable URL of this page
https://metraipolis.com/documento/dc_1336dcd85807

How to cite

Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment — Europe PMC PMID:41632514 — Europe PMC (en), https://europepmc.org/article/MED/41632514 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1336dcd85807 (Metraipolis archive dc_1336dcd85807, sha256 6bbc9e0f375b3c8826daf21eeb609d746e8c99a7e435b23a4b86771c29eef6f9)
BibTeX
@misc{dc1336dcd85807,
  title = {Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment — Europe PMC PMID:41632514},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41632514},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1336dcd85807; sha256 6bbc9e0f375b3c8826daf21eeb609d746e8c99a7e435b23a4b86771c29eef6f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41632514. Agents can read the archived copy with the MCP tool read_document.